Guidance

Antiviral resistance testing in the management of hepatitis C

PHE HCV Resistance Group information on the use of hepatitis C virus resistance testing in clinical practice.

• From: Public Health England
• Published: 7 December 2018

This publication was withdrawn on 13 October 2022

This information is now available at Science Direct.

Documents

Antiviral resistance testing in the management of hepatitis C virus infection

Ref: PHE publications gateway number: 2018603

PDF, 1.16 MB, 48 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This working document, written by Public Health England’s (PHE) Hepatitis C Virus Resistance Group, aims to support clinicians treating people with HCV, where the issue of resistance may be a factor in clinical decision-making.

Published 7 December 2018